+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "T Cell Receptor"

Monoclonal Antibodies (MAs) Global Market Report 2024 - Product Thumbnail Image

Monoclonal Antibodies (MAs) Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
T Cell Therapy Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Modality, Therapy Type [CAR T-cell Therapy and T-cell Receptor-based], Indication, and Geography - Product Thumbnail Image

T Cell Therapy Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Modality, Therapy Type [CAR T-cell Therapy and T-cell Receptor-based], Indication, and Geography

  • Report
  • September 2023
  • 138 Pages
  • Global
From
T-Cell Receptor (TCR) Therapy - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

T-Cell Receptor (TCR) Therapy - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • May 2023
  • 200 Pages
  • Global
From
Middle East & Africa T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

Middle East & Africa T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 90 Pages
  • Middle East, Africa
From
Europe T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

Europe T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 78 Pages
  • Europe
From
Asia Pacific T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

Asia Pacific T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 76 Pages
  • Asia Pacific
From
North America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

North America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 70 Pages
  • North America
From
Global Market for Regenerative Medicine (RM), 2019 - Product Thumbnail Image

Global Market for Regenerative Medicine (RM), 2019

  • Report
  • July 2019
  • 391 Pages
  • Global
From
South & Central America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

South & Central America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 55 Pages
From
Protein Engineering for Therapeutics, Part A. Methods in Enzymology Volume 502 - Product Thumbnail Image

Protein Engineering for Therapeutics, Part A. Methods in Enzymology Volume 502

  • Book
  • February 2012
  • 10 Results (Page 1 of 1)
Loading Indicator

The T Cell Receptor (TCR) market is a subset of the biopharmaceutical industry that focuses on the development of therapeutics that target T cells. T cells are a type of white blood cell that play a key role in the body's immune system. TCRs are proteins that are expressed on the surface of T cells and are responsible for recognizing and binding to antigens. Therapeutics that target TCRs are being developed to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. The TCR market is a rapidly growing field, with many companies investing in research and development. Companies are developing novel TCR-based therapies, such as chimeric antigen receptor T cell (CAR-T) therapies, which are designed to target specific antigens on cancer cells. Additionally, companies are exploring the use of TCRs to develop vaccines and immunotherapies. Some companies in the TCR market include Kite Pharma, Juno Therapeutics, Adaptimmune, and Cellectis. Show Less Read more